Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Revenue | 88M | 71M |
| Research and development | 12M | 10M |
| Selling, general and administrative | 88M | 80M |
| Operating expenses | 116M | 106M |
| Operating income | −28M | −34M |
| Net income | −35M | −43M |
| Earnings per share | −4.67 | −6.64 |
| Earnings per share, diluted | −4.67 | −6.64 |
| Weighted average shares | 8M | 6M |
| Weighted average shares, diluted | 8M | 6M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 26M | 19M | 17M | 21M | 18M | 26M | 31M | 42M |
| Receivables | 10M | 9M | 13M | 7M | 8M | 9M | 8M | 10M |
| Current assets | 41M | 33M | 33M | 32M | 30M | 39M | 44M | 58M |
| Property, plant and equipment | 24M | 25M | 25M | 26M | 27M | 28M | 29M | 28M |
| Goodwill | 15M | 15M | 15M | 15M | 15M | 15M | 15M | 15M |
| Total assets | 95M | 87M | 89M | 88M | 86M | 97M | 103M | 116M |
| Current liabilities | 14M | 17M | 18M | 15M | 13M | 14M | 13M | 18M |
| Total liabilities | 86M | 90M | 90M | 87M | 75M | 76M | 75M | 80M |
| Equity | 9M | −2M | −2M | 1M | 11M | 21M | 28M | 36M |
| Shares outstanding | 10M | 8M | 8M | 147M | 146M | 7M | 145M | 145M |
| Shares issued | 10M | 8M | 8M | 147M | 146M | 7M | 145M | 145M |
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Operating cash flow | −23M | −49M |
| Depreciation and amortisation | 6M | 6M |
| Share-based compensation | 4M | 7M |
| Capital expenditure | 259,000 | 3M |
| Investing cash flow | −403,000 | −3M |
| Financing cash flow | 16M | 52M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator